Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Top tip for an Advent city break: experience the magic of Christmas in Freiburg

Do you fancy seeing the Christmas lights and soaking up that festive feeling? With more than 100 charmingly decorated stalls, lovely crafts and handmade textiles, delicious home-made mulled wine and extraordinary guided tours with a drag queen, the Christmas market in Freiburg from 17 November to 23 December 2022 is a must. Thousands of twinkling lights and a unique lighting system bathe the city centre and Colombipark in a glow of sparkling winter lights.Foodie variety and a winter light spectacular Typical regional treats on offer include bags of hot roasted chestnuts, marzipan and

Axfoundation is the winner of the Swedish consumer prize Blåslampan 2020

Axfoundation runs several programs, each containing different research projects. The Future Food program aims to accelerate the transition to sustainable food systems, and at Axfoundations farm Torsåker, efforts and investments are being made to increase the pace of Swedish sustainable food innovation. Today Axfoundation is awarded the consumer prize Blåslampan for their work within the Future Food program. Blåslampan is a consumer award instituted by the organization Sveriges Konsumenter (Swedish Consumers' Association) and the newspaper Råd & Rön. Each year, the award is given to a

Nomination Committee appointed ahead of Collector Bank’s AGM 2023

Collector Bank AB’s Annual General Meeting will be held on Thursday 4 May 2023. It is hereby announced that the company’s largest shareholders have appointed a Nomination Committee.The Nomination Committee has, ahead of the Annual General Meeting 2023, the following composition: · Sharam Rahi, appointed by Fastighets AB Balder, · Jesper Mårtensson, appointed by Förvaltnings AB Färgax, · Anna-Maria Lundström, appointed by StrategiQ Capital AB, and · Erik Selin, Chairman of the Board of Collector Bank AB. Sharam Rahi has been appointed Chairman of the Nomination Committee.

Smartoptics takes leading role in sustainable optical networking

Oslo, Norway – October 25, 2022 – Smartoptics, a leading provider of optical networking solutions, today presents how its latest solutions are leading the green transition and optimizing energy costs in optical networking. These will support both enterprises and service providers in achieving increased efficiency and meeting sustainability targets.In an environment of increasing electricity prices and greater environmental awareness, optimizing power consumption and improving energy efficiency are priorities for both the enterprise DCI (Data Center Interconnect) segment and operators of

Invitation to Eltel’s Q3 2022 report presentation

Eltel will publish its report for the period January-September 2022 on Wednesday 2 November 2022 at approximately 08.00 am CET. On the same day, we are inviting investors, analysts and media to a combined webcast and teleconference starting at 10:00 am CET.The report for the period January-September 2022 will be presented by Eltel’s President and CEO Håkan Dahlström and CFO Saila Miettinen-Lähde. The presentation will be held in English. Link to webcast: www.eltelgroup.com. You can access the teleconference by registering on the link below. After registration you will be provided

Recipharm bolsters blow-fill-seal capabilities with Lab+

Global contract development and manufacturing organisation (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for low volume blow-fill-seal (BFS) filling at its facility in Kaysersberg, France. BFS is an automated manufacturing process where plastic ampoules are blow-formed, filled, and sealed in a continuous operation. Recipharm offers sterile BFS contract manufacturing for a range of pharmaceutical products and applications including gels, solutions, suspensions, emulsions and aseptically packed single-use vaccines. With a throughput

Beijer Electronics Group informs about new financing

Beijer Electronics Group AB has signed a new financing agreement with Danske Bank and Svensk Exportkredit. The agreement includes SEK 1,000 million in bank loans with an option to borrow an additional SEK 200 million and runs for three years with the possibility of further extension for up to two years.“This is a good agreement for BEIJER GROUP, which partly means that we secure our financing at market conditions, and partly gives us muscle to continue to pursue an active M&A agenda in line with our strategy. We continuously evaluate complementary acquisition objects,” says Joakim Laurén,

One more central bank to use Safeture platform

Falck Global Assistance, a risk management partner to Safeture, has signed a new agreement with another major central bank in Europe. The agreement is part of a four-year framework regarding travel risk management for the European Central Bank (ECB).In January, with its partner Falck Global Assistance, Safeture  won a public procurement for a four-year framework agreement regarding travel risk management for the European Central Bank (ECB) in Frankfurt, Germany. The agreement opened up the opportunity to join other institutions, such as the Central Banks of the

Crayon reports 55% gross profit increase in Q3

Increased demand for IT services globally fuels strong performance(OSLO, Norway) — Crayon announced its financial results for the third quarter today that showed strong growth across all markets, which was largely driven by its customer-centric business model in a global market that has a continued demand for IT services. Crayon had gross sales that were NOK 7,774m, up 51% YOY, and a gross profit of NOK 993m, up 55% YoY. The Oslo-based company also had an adjusted EBITDA of NOK 127m, up 57% from the year before. “This rise in demand for IT services, combined with our customer-centric

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 219 - 25 OCTOBER 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

SmartCraft ASA (SMCRT) - Invitation to presentation of third quarter 2022 results

SmartCraft ASA | Non-regulatory press releases 25 October 2022 - SmartCraft ASA will publish its third quarter 2022 financial report on Tuesday 1 November 2022 at 07:00 CET together with the Q3 2022 presentation material on the company website and www.newsweb.no. Investors, analysts, and journalists are welcome to join to an English language webcast presentation of the report on the same day, Tuesday 1 November 2022, at 08:00 CET. Webcast link: https://channel.royalcast.com/landingpage/hegnarmedia/20221101_2/ Presenters: · Chief Executive Officer Gustav Line · Chief

Wellspect HealthCare announces commitment to climate action with the Science Based Targets initiative (SBTi)

With its vision set on a net-zero value chain by 2045 and a significant reduction of emissions as early as 2030, Wellspect HealthCare (“Wellspect”), a subsidiary of Dentsply Sirona, Incorporated (“Dentsply Sirona”) is now announcing its commitment to the Science Based Targets initiative (“SBTi”). This commitment includes the setting of near- and long-term company-wide emission reductions in line with science-based net-zero with the SBTi. An independent verification and approval by the SBTi of Wellspect’s near and long-term targets is yet to follow. “Sustainability is part of our

Swedish fintech Krea makes SME loans more accessible and affordable thanks to Klarna Kosma

London, 25 October, 2022 - Klarna Kosma, Klarna's financial technology platform for banks, fintechs and innovative retailers, today announced that its partnership with Krea, a digital loans platform for Small and Medium-sized businesses (SMEs) in Sweden has helped Swedish SMEs receive on average 15% larger loan offers, at a 4% lower interest rate.  Krea offers SMEs a single portal where they can apply for business loans from the largest network of lenders in Sweden. SMEs enter the details of their business and loan request into the Krea platform, which shares them with over 30 banks and

Read original

Volvo Group spins out new company Fyrqom AB

Volvo Group, Qamcom Group and the inventor Roman Iustin form a new start-up company, Fyrqom AB. The new company will offer an automated system for calibration of the tire pressure monitoring system on heavy-duty vehicles.With a tire pressure monitoring system, the driver is informed if one of the tires loses the pressure. Today rather few heavy-duty vehicles are equipped with such a system. From 2024 though there is a legal demand in Europe that all trucks and trailers should have such a system. Today the tire pressure monitoring system must be calibrated manually on every truck when they

EQT Foundation invests in Vara, a full stack AI platform making data-driven breast cancer screening accessible to those who need it most

EQT Foundation is pleased to announce its investment in Vara , a healthtech company combining AI with the expertise of leading radiologists, redefining breast cancer screening by making it more accessible, effective and measurable. Originally spun out of the German AI-venture studio Merantix in 2018, Vara has built an intelligent end-to-end AI platform for breast cancer screening, delivering measurable impact by increasing the productivity of the screening physicians, while lowering the risk of not detecting cancer. With the mission to make data-driven breast cancer

Saab Signs Contract with Lithuania for RBS 70 Missiles

Saab has signed a four-year contract with the Lithuanian Defence Materiel Agency, which will allow the customer to place orders for RBS 70 missiles until 2026. A first purchase within the new contract has also been placed, with an order value of SEK 350 million. Deliveries will take place 2023-2024.The order includes missiles for Saab’s ground-based air defence system RBS 70, which Lithuania has been a user of since 2004. “Our best-in-class short range air defence missiles delivers a tactical advantage. The recent contract will further strengthen Lithuania’s air defence capability

DNV qualifies Aker Carbon Capture’s Just Catch Offshore™: ready to cut emissions from oil and gas production

The Just Catch Offshore™, a modularized carbon capture facility for offshore installations, has been successfully qualified by DNV, the global independent energy expert and assurance provider. It is now ready to be deployed in offshore oil and gas fields where Aker Carbon Capture’s proprietary solution can significantly reduce emissions from offshore power generation.“DNV’s recently published Energy Transition Outlook report reveals that Carbon Capture and Storage (CCS) is indispensable for global decarbonization efforts, across multiple industry sectors. We are pleased to provide

Neuraxpharm steps into the Digital Health market with a wearable device developed by mjn-neuro that provides an early warning of epileptic seizures

The CNS specialist Neuraxpharm has signed a commercialisation agreement with mjn-neuro with exclusivity in Europe Düsseldorf and Barcelona / Blanes, Girona, October 25, 2022 - Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and mjn-neuro, a start-up that designs, manufactures and markets medical devices, today announce the signing of a commercialisation agreement for mjn-SERAS, a wearable medical device that aims to predict the risk of having an epileptic seizure.With this agreement, Neuraxpharm increases

Covid-19 dominates among the world’s 10 largest vaccine companies

The global Covid-19 pandemic has changed many aspects of our society. This is especially true in the medical world, where the new vaccines have completely overturned the prevailing hierarchy among the world’s vaccine manufacturers. Today the four largest vaccine manufacturing companies are Covid-19 vaccine manufacturers.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/covid-19-dominates-among-the-worlds-10-largest-vaccine-companies/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Photocure ASA: Invitation to presentation of third quarter 2022 financial results

Oslo, Norway, 25 October 2022: Photocure ASA (Photocure, PHO: OSE) will announce the third quarter 2022 financial results on Wednesday 2 November 2022 at 08:00 CEST and will present a live webcast at 14:00 CEST the same day.The quarterly report and presentation will be published at 08:00 CEST and will be publicly available at www.photocure.com. The investor presentation will be streamed live and be hosted by Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at

UPM Interim Report Q3 2022: UPM delivers all-time high quarterly results with excellent performance in all businesses

UPM-Kymmene Corporation        Stock Exchange Release (Interim Report)        25 October 2022 at 09:40 EEST UPM Interim Report Q3 2022:UPM delivers all-time high quarterly results with excellent performance in all businesses Q3 highlights · Sales increased by 36% to EUR 3,420 million (2,523 million in Q3 2021) · Comparable EBIT grew by 84% to EUR 779 million, 22.8% of sales (424 million, 16.8%) · Operating cash flow was EUR -201 million (318 million), impacted by cash flow from energy hedges. Other operating cash flows were largely as expected · The rise in energy

HC Andersen Capital Events 25/10: Meet the top management in OrderYOYO

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.OrderYOYO - Q3 trading updateLast week OrderYOYO announced its Q3 2022 trading update, implying that the company has reported its key financials and not a comprehensive financial report. Total ARR increased to DKK 185m (25% growth compared to consolidated Q3 2021 proforma numbers with app smart), meaning that OrderYOYO in Q3 has achieved the low end of the newly upgraded December 2022 ARR guidance of DKK 185-200m. OrderYOYO also highlights that

Alelion is planning for a higher order intake than expected for 2023

Current forecasts from Alelion's European customers confirm the contribution to a tremendous growth. A previously communicated order value of SEK 53 million over four years is now approaching an annual turnover of SEK 60 million as early as 2023.In previous communication, on June 8, 2021, Alelion communicated the company's largest order to date of SEK 53 million with deliveries planned over four years. A customized battery system has been developed for the customer's vehicle, which is used primarily in ports in a global market. Today, order placement has transitioned from individual orders

Realheart Featured in German TV Documentary

Press Release 25 October, 2022 Realheart's artificial heart is featured in a German TV documentary about heart disease and new scientific developments that will be broadcast on ZDF tonight, 25 October, at 8.15 PM.The documentary, entitled ''Horst Licther: Mein Herz, mein Motor'', follows a heart failure patient on the waiting list for a transplant. It also highlights the shortage of donor hearts and the need for new technology in artificial hearts. Both Realheart's founder Dr Azad Najar and Dr Dilek Gürsoy, who is part of the company's surgical team for the ongoing animal studies, are

There are no items matching the current filter
There are no more items matching the current filter
Back to top